Related Experiment Video
Updated: Jun 19, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Are all clinical studies sponsored by industry not valid?
1Profil Institut für Stoffwechselforschung, Neuss, Germany. lutz.heinemann@profl-research.de
Journal of Diabetes Science and Technology
|November 4, 2009
Summary
Academic skepticism towards industry science stems from a lack of understanding. Despite perceived risks, industry studies often maintain high data quality due to regulatory oversight, suggesting a need for better communication between sectors.
Area of Science:
- Pharmaceutical Research
- Scientific Integrity
- Industry-Academia Relations
Background:
- Industry-sponsored studies face reputational challenges, leading some journals to mandate independent statistical reviews.
- A prevalent belief exists that academic science is inherently superior to industry-driven research.
Purpose of the Study:
- To explore the reasons behind academic skepticism towards industry-sponsored science.
- To compare the scientific rigor and data quality between academic and industry research settings.
- To identify potential areas for improved collaboration and mutual understanding.
Main Methods:
- This commentary analyzes the perceptions and realities of scientific research in both academic and industrial settings.
- It discusses the pressures for publication and the potential for fraud in both environments.
- It highlights the role of regulatory bodies in ensuring data quality in industry-sponsored studies.
Main Results:
- The pressure to publish significant findings exists in both academic and industry research, posing a risk of fraud in both.
- Industry-sponsored studies benefit from higher regulatory control, ensuring superior data quality.
- Skepticism towards the pharmaceutical industry often arises from a lack of awareness regarding its demanding and scientific nature.
Conclusions:
- The quality of data in industry-driven studies is high due to stringent regulatory oversight.
- Improved communication and mutual understanding are crucial for bridging the gap between academic and industry research communities.
- The pharmaceutical industry should enhance its public relations to counter its negative image.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...